On disruption of fear memory by reconsolidation blockade: Evidence from cannabidiol treatment

Neuropsychopharmacology

Volumn 37, Issue 9, 2012, Pages 2132-2142

  Stern, Cristina A J ^a   Gazarini, Lucas ^a   Takahashi, Reinaldo N ^a   Guimarães, Francisco S ^b   Bertoglio, Leandro J ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

cannabidiol; fear extinction; fear memory; midazolam; reconsolidation blockade

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABIDIOL; CANNABINOID 1 RECEPTOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEAR; MALE; MEMORY; MEMORY CONSOLIDATION; NONHUMAN; PRIORITY JOURNAL; RAT; SOCIAL ENVIRONMENT;

ANIMALS; CANNABIDIOL; CONDITIONING (PSYCHOLOGY); EVIDENCE-BASED MEDICINE; EXTINCTION, PSYCHOLOGICAL; FEAR; MALE; MEMORY; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1;

EID: 84863981429     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.63     Document Type: Article

References (57)

1. Akirav I, Khatsrinov V, Vouimba RM, Merhav M, Ferreira G, Rosenblum K et al (2006). Extinction of conditioned taste aversion depends on functional protein synthesis but not on NMDA receptor activation in the ventromedial prefrontal cortex. Learn Mem 13: 254-258.
2. Akirav I, Maroun M (2006). Ventromedial prefrontal cortex is obligatory for consolidation and reconsolidation of object recognition memory. Cerebral Cortex 16: 1759-1765.
3. Alberini CM (2011). The role of reconsolidation and the dynamic process of long-term memory formation and storage. Front Behav Neurosci 7: 5-12.
4. Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Nosarti C, O'Carroll C et al (2009). Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch Gen Psychiatry 66: 442-451.
5. Bergamaschi MM, Queiroz RH, Chagas MH, de Oliveira DC, De Martinis BS, Kapczinski F et al (2011). Cannabidiol reduces the anxiety induced by simulated public speaking in treatmentna? ̈ve social phobia patients. Neuropsychopharmacology 36: 1219-1226.
6. Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I et al (2001). Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 134: 845-852.
7. Bitencourt RM, Pamplona FA, Takahashi RN (2008). Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. Eur Neuropsychopharmacol 18: 849-859.
8. Blanchard RJ, Blanchard DC (1969). Passive and active reactions to fear-eliciting stimuli. J Comp Physiol Psychol 68: 129-135.
9. Boccia MM, Blake MG, Krawczyk MC, Baratti CM (2011). Sildenafil, a selective phosphodiesterase type 5 inhibitor, enhances memory reconsolidation of an inhibitory avoidance task in mice. Behav Brain Res 220: 319-324.
10. Bustos SG, Giachero M, Maldonado H, Molina VA (2010). Previous stress attenuates the susceptibility to midazolam's disruptive effect on fear memory reconsolidation: influence of prereactivation D-cycloserine administration. Neuropsychopharmacology 35: 1097-1108.
11. Bustos SG, Maldonado H, Molina VA (2006). Midazolam disrupts fear memory reconsolidation. Neuroscience 139: 831-842.
12. Bustos SG, Maldonado H, Molina VA (2009). Disruptive effect of midazolam on fear memory reconsolidation: decisive influence of reactivation time span and memory age. Neuropsychopharmacology 34: 446-457.
13. Campos AC, Guimarães FS (2008). Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology (Berl) 199: 223-230.
14. Casarotto PC, Gomes FV, Resstel LB, Guimarães FS (2010). Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors. Behav Pharmacol 21: 353-358.
15. de Oliveira Alvares L, Pasqualini Genro B, Diehl F, Molina VA, Quillfeldt JA (2008). Opposite action of hippocampal CB1 receptors in memory reconsolidation and extinction. Neuroscience 154: 1648-1655.
16. Debiec J, Doyère V, Nader K, Ledoux JE (2006). Directly reactivated, but not indirectly reactivated, memories undergo reconsolidation in the amygdala. Proc Natl Acad Sci USA 103: 3428-3433.
17. Debiec J, Ledoux JE (2004). Disruption of reconsolidation but not consolidation of auditory fear conditioning by noradrenergic blockade in the amygdala. Neuroscience 129: 267-272.
18. Debiec J, LeDoux JE, Nader K (2002). Cellular and systems reconsolidation in the hippocampus. Neuron 36: 527-538.
19. Deiana S, Watanabe A, Yamasaki Y, Amada N, Arthur M, Fleming S et al (2012). Psychopharmacology (Berl) 219: 859-873.
20. Dudai Y (2004). The neurobiology of consolidations, or, how stable is the engram? Annu Rev Psychol 55: 51-86.
21. Dudai Y (2006). Reconsolidation: the advantage of being refocused. Curr Opin Neurobiol 16: 174-178.
22. Duvarci S, Nader K (2004). Characterization of fear memory reconsolidation. J Neurosci 24: 9269-9275.
23. Duvarci S, Nader K, LeDoux JE (2005). Activation of extracellular signal-regulated kinase-mitogen-activated protein kinase cascade in the amygdala is required for memory reconsolidation of auditory fear conditioning. Eur J Neurosci 21: 283-289.
24. Eisenberg M, Kobilo T, Berman DE, Dudai Y (2003). Stability of retrieved memory: inverse correlation with trace dominance. Science 301: 1102-1104.
25. Fanselow MS (2010). From contextual fear to a dynamic view of memory systems. Trends Cogn Sci 14: 7-15.
26. Gatley SJ, Gifford AN, Volkow ND, Lan R, Makriyannis A (1996). 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. Eur J Pharmacol 307: 331-338.
27. Guimarães FS, Chiaretti TM, Graeff FG, Zuardi AW (1990). Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology (Berl) 100: 558-559.
28. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR et al (1990). Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87: 1932-1936.
29. Herry C, Trifilieff P, Micheau J, Lüthi A, Mons N (2006). Extinction of auditory fear conditioning requires MAPK/ERK activation in the basolateral amygdala. Eur J Neurosci 24: 261-269.
30. Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R (2009). Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 30: 515-527.
31. Kobilo T, Hazvi S, Dudai Y (2007). Role of cortical cannabinoid CB1 receptor in conditioned taste aversion memory. Eur J Neurosci 25: 3417-3421.
32. Lattal KM, Abel T (2004). Behavioral impairments caused by injections of the protein synthesis inhibitor anisomycin after contextual retrieval reverse with time. Proc Natl Acad Sci USA 101: 4667-4672.
33. Lee JL (2010). Memory reconsolidation mediates the updating of hippocampal memory content. Front Behav Neurosci 4: 168.
34. Lee JL, Everitt BJ, Thomas KL (2004). Independent cellular processes for hippocampal memory consolidation and reconsolidation. Science 304: 839-843.
35. Lee JL, Milton AL, Everitt BJ (2006). Reconsolidation and extinction of conditioned fear: inhibition and potentiation. J Neurosci 26: 10051-10056.
36. Lin HC, Mao SC, Gean PW (2006). Effects of intra-amygdala infusion of CB1 receptor agonists on the reconsolidation of fearpotentiated startle. Learn Mem 13: 316-321.
37. Milekic MH, Alberini CM (2002). Temporally graded requirement for protein synthesis following memory reactivation. Neuron 36: 521-525.
38. Misanin JR, Miller RR, Lewis DJ (1968). Retrograde amnesia produced by electroconvulsive shock after reactivation of a consolidated memory trace. Science 160: 554-555.
39. Moreira FA, Aguiar DC, Guimarães FS (2006). Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test. Prog Neuropsychopharmacol Biol Psychiatry 30: 1466-1471.
40. Mueller D, Porter JT, Quirk GJ (2008). Noradrenergic signaling in infralimbic cortex increases cell excitability and strengthens memory for fear extinction. J Neurosci 28: 369-375.
41. Nader K, Schafe GE, Le Doux JE (2000). Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature 406: 722-726.
42. Nurmikko TJ, Serpell MG, Hoggart B, Toomey PJ, Morlion BJ, Haines D (2007). Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebocontrolled clinical trial. Pain 133: 210-220.
43. Ogren SO, Eriksson TM, Elvander-Tottie E, D'Addario C, Ekström JC, Svenningsson P et al (2008). The role of 5-HT(1A) receptors in learning and memory. Behav Brain Res 195: 54-77.
44. Pike VW, Halldin C, McCarron JA, Lundkvist C, Hirani E, Olsson H et al (1998). [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo. Eur J Nucl Med 25: 338-346.
45. Przybyslawski J, Roullet P, Sara SJ (1999). Attenuation of emotional and nonemotional memories after their reactivation: role of beta adrenergic receptors. J Neurosci 19: 6623-6628.
46. Rescorla RA (2004). Spontaneous recovery varies inversely with the training-extinction interval. Learn Behav 32: 401-408.
47. Resstel LB, Tavares RF, Lisboa SF, Joca SR, Corrêa FM, Guimarães FS (2009). 5-HT1A receptors are involved in the cannabidiolinduced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats. Br J Pharmacol 156: 181-188.
48. Rodriguez-Ortiz CJ, Garcia-DeLaTorre P, Benavidez E, Ballesteros MA, Bermudez-Rattoni F (2008). Intrahippocampal anisomycin infusions disrupt previously consolidated spatial memory only when memory is updated. Neurobiol Learn Mem 89: 352-359.
49. Russo EB, Burnett A, Hall B, Parker KK (2005). Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem Res 30: 1037-1043.
50. Sara SJ (2000). Retrieval and reconsolidation: toward a neurobiology of remembering. Learn Mem 7: 73-84.
51. Schafe GE, LeDoux JE (2000). Memory consolidation of auditory pavlovian fear conditioning requires protein synthesis and protein kinase A in the amygdala. J Neurosci 20: RC96.
52. Steckler T, Risbrough V (2012). Pharmacological treatment of PTSD-established and new approaches. Neuropharmacology 62: 617-627.
53. Suzuki A, Josselyn SA, Frankland PW, Masushige S, Silva AJ, Kida S (2004). Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci 24: 4787-4795.
54. Suzuki A, Mukawa T, Tsukagoshi A, Frankland PW, Kida S (2008). Activation of LVGCCs and CB1 receptors required for destabilization of reactivated contextual fear memories. Learn Mem 15: 426-433.
55. Taubenfeld SM, Riceberg JS, New AS, Alberini CM (2009). Preclinical assessment for selectively disrupting a traumatic memory via postretrieval inhibition of glucocorticoid receptors. Biol Psychiatry 65: 249-257.
56. Yamada D, Zushida K, Wada K, Sekiguchi M (2009). Pharmacological discrimination of extinction and reconsolidation of contextual fear memory by a potentiator of AMPA receptors. Neuropsychopharmacology 34: 2574-2584.
57. Yehuda R, Joëls M, Morris RG (2010). The memory paradox. Nat Rev Neurosci 11: 837-839.